SecBot SecBot
424B5 ·Filed Apr 27, 2026

ORKA

Oruka Therapeutics, Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed6mo ago SEC0001213900-26-048099
Actionable Insight ▼ Bearish

Expect downward pressure on ORKA stock as the market prices in dilution from this large follow-on. Monitor pricing of the offerings and any concurrent news on clinical pipeline or cash burn. The second undisclosed offering adds uncertainty.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$73.99
T+0 close · Apr 27, 2026 · via day close
Latest settled
+24.27%
T+60 · $91.95
Vs SPY
+20.28%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 28 $73.99entry
  2. T+1 · 7mo ago −6.08%α −6.07% · $69.49
  3. T+5 · 7mo ago −10.18%α −11.87% · $66.46
  4. T+20 · 6mo ago −20.18%α −25.65% · $59.06
  5. T+60 · 4mo ago +24.27%α +20.28% · $91.95
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Oruka Therapeutics filed two preliminary prospectus supplements for a combined equity offering of at least $500 million (plus $75 million overallotment) under its $1 billion shelf registration. The company estimates $496 million cash on hand as of March 31, 2026, and intends to use proceeds for general corporate purposes including R&D and working capital. The substantial dilution from this large follow-on offering is bearish for the stock.

Key Facts

  • Offering $500,000,000 of common stock and pre-funded warrants, plus underwriter option for $75,000,000 additional shares
  • Second concurrent common stock offering of undisclosed amount (placeholder $[] )
  • Cash, cash equivalents, and investments approximately $496 million as of March 31, 2026
  • Historical net tangible book value of $471.9 million ($9.69 per share) as of December 31, 2025
  • Stock price $69.03 on April 24, 2026; market cap ~$3.4B

Financial Impact

Dilution of at least 15-20% of market cap from $500M+ offering; exact dilution depends on pricing and size of second offering

dilution

Risk Factors

  • Significant equity dilution diluting existing shareholders
  • Potential further offerings if all of $1B shelf is utilized
  • No revenue or profitability to offset dilution concerns

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (ORKA), Batch item 10001213900-26-048099
Document: 0001213900-26-048099-index-headers.html0001213900-26-048100
Document: 0001213900-26-048099-index.html0001213900-26-048099
Document: 0001213900-26-048099.txt0001213900-26-048099
424B5 Filing (ORKA), Batch item 50001213900-26-048100

Track record

40 reports on ORKA

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 10 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
  4. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  6. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  7. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
  8. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  9. Nov 2, 202614d ago 144 Neutral 3/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
Showing 10 of 40

US Market Status

Market Closed · Opens in 9h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 27, 2026